Siemens supports Indivior to set new standards with automated plant in Hull
20 Aug 2023
Siemens is supporting global manufacturer of addiction and mental health treatment medicines Indivior to help create a 1,731 sq ft automated Active Pharmaceutical Ingredient (API) manufacturing facility at its UK base in Hull.
It will house three new reactors, filter driers and a powder transfer system to enable Indivior to optimise production of its API Buprenorphine Hydrochloride. The project will see Siemens implement its most advanced SIMATIC PCS neo web-based process control system.
Security measures will also be preconfigured by Siemens at the point of construction to ensure plant and network security as well as system integrity and the system will also support enhanced safety controls using the latest technology.
Project leader, electrical, control and instrumentation engineer Tom Greatorex stated:
“Creating the new facility allows us to improve our manufacturing process and reduce bottlenecking. The implementation of technology helps us to do this in a future-proofed and optimal way.”
In 2021 Indivior selected Siemens to help the firm increase automation and process safety at its UK manufacturing facility, home to 10 reactors.
Alex Caldas, Account Development Manager at Siemens UK and Ireland said: “We have a long-standing relationship with Indivior, supporting the business with the latest technology to help it transform. Crucially, this has meant helping Indivior maintain a safe environment across its facilities, while also enhancing its production to meet ongoing growth ambitions.”
